Sunday, March 18, 2018 5:53:48 PM
You said:
Now read this statement from DECN:
Could you explain how you came to the conclusion that the outcome of the current infringement case (as yet unresolved ) has "little or no bearing on the sale of the Lifescan franchise" when a significant portion of the revenues are derived from sales of the strips whose patents are in question?
I am in no way implying that DECN is on the verge of winning $400 million based on this case. The current share price of 0.05 says the market agrees. My point is that if there was historical infringement by JNJ of a patent that was valid at that time it would seem to imply that going forward they may not have the same leverage/tools available to them to maintain market dominance. If the current case were to be decided against JNJ (wouldn't be the fist time they lost) why wouldn't that impact the value of the franchise regardless of who owns it?
Thanks for your insight.
regards
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM